KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Lucknow: King George’s Medical University (KGMU) will file an FIR against four employees after a probe found alleged irregularities worth around Rs 2.5 crore in medicines procurement under the Asadhya Yojana. The scheme provides free treatment to poor patients with chronic diseases.

A five-member inquiry committee found irregularities in the urology department and recommended action against one regular pharmacist and three contractual employees.

KGMU spokesperson Prof KK Singh said the FIR will be registered on Tuesday.

The matter came to light after officials noticed a sharp rise in medicine expenditure, which jumped from Rs 10 lakh a month to Rs 40 lakh in Feb and Rs 45 lakh in March, triggering an audit that revealed discrepancies.
Each injection costs between Rs 8,000 and Rs 10,000.

It also found cases where medicines were shown as administered without the patient being admitted. This raised suspicion of misuse of govt funds.

The inquiry flagged violations of drug management procedures. A contractual employee handled the ordering and receipt of medicines, violating the rule that assigns authorised nursing staff to perform this task.

The committee suspects that these medicines may have been diverted and is examining where the drugs were disposed of. The panel recommended criminal proceedings against the four employees.

KGMU stopped payments for medicines under scrutiny and constituted a committee on the directions of vice-chancellor Prof Soniya Nityanand.

The panel examined patient records, distribution registers and payment data. It found that medicines were shown as consumed beyond the prescribed dosage.

In several cases, an injectable drug meant to be administered once every six months was shown as administered four to five times in a month.

Related Posts

Haryana Launches ‘Make in Haryana Industrial Policy’

Gurugram: Haryana moved to sharpen its pitch as one of India’s most competitive industrial and investment destinations as Chief Minister Nayab Singh Saini launched the Make in Haryana Industrial Policy 2026…

A new pancreatic cancer pill may be a game changer for patients

While not a cure, the drug nearly doubles patients’ survival time versus chemotherapy An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Haryana Launches ‘Make in Haryana Industrial Policy’

Haryana Launches ‘Make in Haryana Industrial Policy’

A new pancreatic cancer pill may be a game changer for patients

A new pancreatic cancer pill may be a game changer for patients

NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

Industry asks NPPA to implement SOTS Scheme to resolve pending litigations